Abbrev |
Full Spell-Out |
2D |
two-dimensional |
3D |
three-dimensional |
3D-CRT |
three-dimensional conformal radiation therapy |
5-FU |
5-fluoro uracil |
ABMT |
autologous bone marrow transplant |
abnl |
abnormal |
ACTH |
adrenocorticotropic hormone |
ADH |
antidiuretic hormone |
adj |
adjuvant |
Adr |
Adriamycin |
AFP |
alpha-feto protein |
AIDS |
acquired immune deficiency syndrome |
AJCC |
American Joint Committee on Cancer |
aka |
also known as |
alk phos |
alkaline phosphatase |
am |
morning (ante meridian) |
ANC |
absolute neutrophil count (lab) |
ant |
anterior |
anterolat |
anterolateral |
AP |
anterior-posterior |
APC |
adenomatous polyposis coli (gene mutation) |
ARUBA |
A Randomized Trial of Unruptured Brain Arteriovenous Malformations |
ASCUS |
atypical squamous cells of unknown significance |
ASTRO |
American Society for Therapeutic Radiation and Oncology |
AUC |
area under the curve |
avg |
average |
BAT |
B-mode acquisition and targeting |
b/c |
because |
β-HCG |
beta-human chorionic gonadotropin |
bid |
twice daily |
bilat |
bilateral |
BM |
bone marrow |
BMI |
body mass index |
BMP |
basic metabolic panel |
BMT |
bone marrow transplant |
BTSG |
Brain Tumor Study Group |
Bx |
biopsy/biopsies |
C |
cervical (spine level) |
CA 19-9 |
cancer antigen 19-9 |
CA 125 |
cancer antigen 125 |
CALGB |
Cancer and Leukemia Group B |
C/A/P |
chest/abdomen/pelvis |
CBC |
complete blood count (lab) |
CCCG |
Colorectal Cancer Collaborative Group |
cCR |
clinical complete response |
CD |
cone-down |
CD4 |
cluster of differentiation 4 (for immune cells) |
CEA |
carcinoembryonic antigen |
CESS |
Cooperative Ewing Sarcoma Study |
CHART |
Continuous Hyperfractionated Accelerated Radiotherapy Trial |
chemo |
chemotherapy |
CHF |
congestive heart failure |
CIN |
cervical intraepithelial neoplasia |
CIS |
carcinoma in situ |
cm |
centimeter/centimeters |
CMP |
complete metabolic panel (lab) |
c-myc |
(gene) |
cN0 |
clinically node-negative |
CN |
cranial nerve |
CNS |
central nervous system |
Co-60 |
cobalt-60 |
COG |
Children's Oncology Group |
contralat |
contralateral |
Cr |
creatinine |
CR |
complete response |
CRT |
chemoradiation |
CSF |
cerebrospinal fluid |
CSI |
craniospinal irradiation |
CSM |
cancer-specific mortality |
CSS |
cause-specific survival |
CT |
computed tomography |
CTV |
clinical target volume |
CXR |
chest x-ray |
D/C |
discontinue/discontinued |
D&C |
dilation and curettage |
DCC |
deleted in colorectal cancer (gene) |
DDx |
differential diagnosis |
DFS |
diseasefree survival |
DLCO |
lung diffusion capacity testing |
DM |
distant metastasis |
DMFS |
distant metastasisfree survival |
DOI |
depth of invasion |
DRE |
digital rectal examination |
DSS |
disease-specific survival |
DVH |
dose volume histogram |
DVT |
deep venous thrombosis |
Dx |
diagnosis/diagnoses |
Dz |
disease/diseases |
EB |
external beam |
EBRT |
external beam radiation therapy |
EBV |
Epstein-Barr virus |
ECE |
extracapsular extension |
ECOG |
Eastern Cooperative Oncology Group |
EFS |
eventfree survival |
e.g. |
for example |
EGFR |
epidermal growth factor receptor |
ENI |
elective nodal irradiation |
EORTC |
European Organisation for Research and Treatment of Cancer |
ESR |
erythrocyte sedimentation rate (lab) |
et al. |
and others |
EUA |
exam under anesthesia |
EUS |
endoscopic ultrasound |
exam |
examination |
FDA |
Food and Drug Administration |
FDG |
fluorine-18 2-fluoro-2-deoxy-D-glucose |
FEV |
forced expiratory volume |
FFS |
failurefree survival |
FIGO |
International Federation of Gynecology and Obstetrics |
FISH |
fluorescence in situ hybridization |
FKHR |
Forkhead (drosophilia) homolog 1 (rhabdomyosarcoma) (gene) |
FLAIR |
fluid attenuation inversion recovery |
F:M |
female to male ratio |
FN rate |
false-negative rate |
FNA |
fine needle aspiration |
FOLFOX |
5-FU/leukovorin/oxaliplatin |
FPR |
false-positive rate |
FSH |
follicle-stimulating hormone |
FSR |
fractionated stereotactic radiotherapy |
fx |
fraction/fractions |
GERD |
gastroesophageal reflux disease |
GH |
growth hormone |
GI |
gastrointestinal |
GnRH |
gonadotropin-releasing hormone |
GTR |
gross total resection |
GTV |
gross target volume |
GU |
genitourinary |
Gy |
Gray |
gyn |
gynecologic |
H&N |
head and neck |
H&P |
history and physical |
HA |
headache |
HAART |
highly active antiretroviral therapy |
HCG |
human chorionic gonadotropin (lab test) |
HDR |
high dose rate |
Hgb |
hemoglobin |
HGSIL |
high-grade squamous intraepithelial lesion |
HIV |
human immunodeficiency virus |
HNPCC |
hereditary nonpolyposis colon cancer |
HPV |
human papilloma virus |
hr/hrs |
hour/hours |
HR |
hazard ratio |
HRT |
hormone replacement therapy |
HSV |
herpes simplex virus |
HTN |
hypertension |
Hx |
history/histories |
IBCSG |
International Breast Cancer Study Group |
ICP |
intracranial pressure |
IDL |
isodose line |
i.e. |
that is |
IELCAP |
International Early Lung Cancer Action Project |
IFN |
interferon |
IgA |
immunoglobulin A |
IGF |
insulinlike growth factor |
IgG |
immunoglobulin G |
IGRT |
image-guided radiation therapy |
IJROBP |
International Journal of Radiation Oncology, Biology, and Physics |
IMRT |
intensity-modulated radiation therapy |
inf |
inferior |
INR |
international normalized ratio |
intraop |
intraoperative |
IORT |
intraoperative radiation therapy |
ipsi |
ipsilateral |
IQ |
intelligence quotient |
ITV |
internal target volume |
IVC |
inferior vena cava |
JAMA |
Journal of the American Medical Association |
JCO |
Journal of Clinical Oncology |
JCOG |
Japan Clinical Oncology Group |
JCRT |
Joint Center for Radiation Therapy |
JNCI |
Journal of the National Cancer Institute |
L |
lumbar (spine level) |
lab |
laboratory/laboratory test |
LAD |
lymphadenopathy |
LAMP |
Locally Advanced Multimodality Protocol |
LAO |
left anterior oblique |
lat |
lateral |
LC |
local control |
LDH |
lactate dehydrogenase |
LDR |
low dose rate |
LEEP |
loop electrosurgical excision procedure |
LF |
local failure |
LFT |
liver function test |
LGSIL |
low-grade squamous intraepithelial lesion |
LH |
luteinizing hormone |
LINAC |
linear accelerator |
LLL |
left lower lobe |
LML |
left middle lobe |
LN |
lymph node |
LND |
lymph node dissection |
LOH |
loss of heterozygosity |
LP |
lumbar puncture |
LPO |
left posterior oblique |
LR |
local recurrence |
LRC |
locoregional control |
LRF |
locoregional failure |
LRFS |
local recurrencefree survival |
LRR |
locoregional recurrence |
LUL |
left upper lobe |
LVI |
lymphovascular invasion |
LVSI |
lymphovascular stromal invasion |
MALT |
mucosa-associated lymphoid tissue |
max |
maximal/maximum |
MDACC |
MD Anderson Cancer Center |
med |
medication |
MEN |
multiple endocrine neoplasia |
mets |
metastasis/metastases |
M:F |
male to female ratio |
MFS |
metastasesfree survival |
MGMT |
O6-methylguanine DNA-methyltransferase |
min |
minimal/minimum |
mo/mos |
month/months |
MRC |
Medical Research Council |
MRI |
magnetic resonance imaging |
MS |
median survival |
MTD |
maximum tolerated/tolerable dose |
MVA |
multivariate analysis |
N/C |
nuclear to cytoplasm ratio |
NCCN |
National Comprehensive Cancer Network |
NCCTG |
North Central Cancer Treatment Group |
NCI |
National Cancer Institute |
NCIC |
National Cancer Institute of Canada |
NED |
no evidence of disease |
NEJM |
New England Journal of Medicine |
neoadj |
neoadjuvant |
NF |
neurofibromatosis |
NPV |
negative predictive value |
NR |
no response |
NSABP |
National Surgical Adjuvant Breast and Bowel Project |
NSAID |
nonsteroidal anti-inflammatory drug |
NSS |
not statistically significant |
NTR |
near-total resection |
n/v |
nausea/vomiting |
NZ |
New Zealand |
OR |
odds ratio |
ORR |
overall response rate |
OS |
overall survival |
PA |
posterior-anterior |
PAP |
Papanicolau |
PCI |
prophylactic cranial irradiation |
PCP |
pneumocystic pneumonia |
PCR |
polymerase chain reaction |
pCR |
pathologic complete response |
PDGFR |
platelet-derived growth factor receptor |
PEG (tube) |
percutanous endoscopic gastrostomy tube |
periop |
perioperative |
PET |
positron emission tomography |
PFS |
progressionfree survival |
PFT |
pulmonary function test |
Plt |
platelets |
pm |
afternoon (post meridian) |
pN0 |
pathologically node negative |
PNET |
primitive neuroectodermal tumor |
PNI |
perineural invasion |
PORT |
postoperative radiation therapy |
post |
posterior |
posterolat |
posterolateral |
postop |
postoperative |
PPV |
positive predictive value |
PR |
partial response |
preop |
preoperative |
PSA |
prostate-specific antigen |
pt/pts |
patient/patients |
PTHrP |
parathyroid hormone–related peptide |
PT |
prothrombin time |
PTV |
planning target volume |
PUVA |
psoralen and long-wave ultraviolet radiation |
q |
every |
qd |
daily |
QOL |
quality of life |
RAO |
right anterior oblique |
RBE |
relative biologic effectiveness |
RCT |
randomized controlled trial |
rcv |
receive/received |
RFS |
relapsefree survival |
RLL |
right lower lobe |
RML |
right middle lobe |
r/o |
rule out |
RPO |
right posterior oblique |
RR |
relative risk |
RT |
radiation or radiation therapy |
RTOG |
Radiation Therapy Oncology Group |
RUL |
right upper lobe |
RUQ |
right upper quadrant |
Rx |
prescription/prescriptions |
S |
sacral (spine level) |
SBO |
small bowel obstruction |
SEER |
Surveillance Epidemiology and End Results (data) |
SFOP |
French Society of Pediatric Oncology |
SIADH |
syndrome of inappropriate secretion of antidiuretic hormone |
SIL |
squamous intraepithelial lesion |
SQ |
subcutaneous |
s/p |
status post |
SPECT |
single photon emission computed tomography |
SRS |
stereotactic radiosurgery |
SS |
statistically significant |
SSD |
source to skin distance |
STD |
sexually transmitted disease |
STR |
subtotal resection |
sup |
superior |
SVC |
superior vena cava |
Sx |
symptom/symptoms |
T |
thoracic (spine level) |
TD |
tolerance dose |
TFT |
thyroid function test |
tid |
three times a day |
TNM |
Tumor/Node/Metastasis |
trilat |
trilateral |
TRUS |
transrectal ultrasound |
TSH |
thyroid-stimulating hormone |
Tx |
treatment/treatments |
UA |
urinalysis |
UCSF |
University of California at San Francisco |
UK |
United Kingdom |
unilat |
unilateral |
US |
ultrasound |
U.S. |
United States |
UV |
ultraviolet |
vs. |
versus |
WBC |
white blood cell |
WBRT |
whole brain radiation therapy |
WHO |
World Health Organization |
wk/wks |
week/weeks |
WLE |
wide local excision |
yo |
year old/years old |
yr/yrs |
year/years |
Symbols |
|
+ |
meaning with or and (as in Surgery + RT) |
→ |
meaning followed by |
↑ |
meaning increasing, high(er), or elevated |
↓ |
meaning decreasing or low(er) |